Αρχική World News FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy World News FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Από Ogkologos - 1 Ιουλίου, 2026 281 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CADENZA study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR 10 Things Diet Soda Does to Your Body If You Drink... 29 Ιουλίου, 2021 FDA Approves Device for Treatment of Osteoid Osteoma in the Extremities 1 Δεκεμβρίου, 2020 Building a Balanced Breakfast 6 Νοεμβρίου, 2020 Cancer Prevention Message Is Key for HPV Vaccination Discussions with Parents 10 Ιουλίου, 2018 Φόρτωση περισσοτέρων HOT NEWS Switching to Camizestrant While Continuing a CDK4/6 Inhibitor After ESR1 Mutation... Can Cooking With Nonstick Cookware Increase Your Cancer Risk? The new home for your research tools Many Men with Penile Cancer Do Not Get Recommended Treatments, Study...